BIOLIFE SOLUTIONS INC SEC Filings

Filed On	Filing
27 Oct 2026	SCHEDULE 13G/A
16 Oct 2026	15-12G
09 Oct 2026	EFFECT
09 Oct 2026	EFFECT
08 Oct 2026	Form 4: Wichterman Troy, Chief Financial Officer Received 138,504 shares as a grant or award · Gave up 95,933 shares to cover exercise price or tax ($3.7M) · Returned 256,000 shares to the issuer
08 Oct 2026	Form 4: Goswami Joydeep, Director Returned 53,156 shares to the issuer
08 Oct 2026	Form 4: Ellingson Rachel, Director Returned 57,995 shares to the issuer
08 Oct 2026	Form 4: DuRoss Amy, Director Returned 26,857 shares to the issuer
08 Oct 2026	Form 4: Coste Catherine, Director Returned 13,871 shares to the issuer
08 Oct 2026	Form 4: De Greef Roderick, Director Received 463,130 shares as a grant or award · Gave up 364,872 shares to cover exercise price or tax ($14.1M) · Returned 826,454 shares to the issuer
08 Oct 2026	Form 4: Hunt Anthony, Director Returned 15,046 shares to the issuer
08 Oct 2026	Form 4: Moore Timothy L., Director Returned 44,943 shares to the issuer
08 Oct 2026	Form 4: Mathew Aby J., EVP & Chief Scientific Officer Received 86,030 shares as a grant or award · Gave up 70,000 shares to cover exercise price or tax ($2.7M) · Returned 404,608 shares to the issuer
08 Oct 2026	Form 4: Berard Todd, Chief Marketing Officer Received 78,390 shares as a grant or award · Gave up 46,170 shares to cover exercise price or tax ($1.78M) · Returned 194,786 shares to the issuer
08 Oct 2026	Form 4: Werner Sean, Chief Technology Officer Received 94,070 shares as a grant or award · Gave up 71,226 shares to cover exercise price or tax ($2.75M) · Returned 69,979 shares to the issuer
06 Oct 2026	S-8 POS
06 Oct 2026	POS AM
06 Oct 2026	POS AM
06 Oct 2026	S-8 POS
06 Oct 2026	S-8 POS

Comments